Summary. Five human brains affected by Alzheimer's disease (AD), but without cerebellar amyloid (A ) deposits, were investigated for the presence and location of amyloid precursor proteins (APP). This was parallel to 6 AD brains with A deposits, 6 young controls and 6 age-matched controls. Antibodies against A and two epitopes of APP (amino and carboxy terminals, APP 60-100 and APP 643-695 , respectively) were employed. Accumulations of APP in neurons (mainly Purkinje cells) and glial cells in the upper part of the molecular layer were far greater than those in age-matched control brains and similar to those in AD brains with A deposits. This suggests that changes in APP production and/or metabolism occur before A deposition, or that these changes can occur without amyloidogenic processing. More than 60% of positive Purkinje neurons were of normal appearance; most of them showed both APP 60-100 and APP 643-695 immunoreactivity, but a small number (Ͻ21%) reacted with only a single antiserum. A small number of Golgi, Lugaro and granule cells were APP immunopositive. In all cases, stellate and basket cells were negative, as were most glial cells other than those of the molecular layer. Folia showed two different appearances, which were particularly well displayed in three cases: "strongly" immunopositive folia with high reactivity in Purkinje cells and other neurons, and "weakly" immunopositive folia with low neuronal reactivity, but with a large number of positive glial cells in the molecular layer. The results are discussed in relation to the possible existence of types or stages of the AD process and local factors, including specific and non-specific cell factors, in the induction of APP accumulation. All these 5 cases were female, but the Apo-E 4 genotype was displayed only in two cases.
Introduction
Increased extracellular deposition of -amyloid ( A4 peptide, A ) is an outstanding feature of Alzheimer's disease (AD) (Masters et al., 1985) . Diverse morphological or immunoreactive variants of amyloid deposits have been described in AD and Down's Syndrome (DS) (Kida et al., 1995; Su et al., 1998; Thal et al., 1998; Wisniewski et al., 1989; Yamaguchi et al., 1988) . In the cerebellum, non-neuritic plaques may be the only manifestation of amyloid deposition (Cataldo et al., 1996; Cole et al., 1993; Joachim et al., 1989; Yamaguchi et al., 1989) . The type of amyloid deposit and the level of amyloid burden may depend on different factors which give rise to, modify or reduce the deposition of A and other plaque components (Armstrong et al., 1995; Cataldo et al., 1996; Hyman et al., 1993) . The A component of all these deposits is thought to derive from several isoforms of a unique precursor, the -amyloid precursor protein (APP) in an amyloidogenic process (Mills and Reiner, 1999; Sandbrink et al., 1994; Selkoe et al., 1996) . Although APP isoforms are evidently key macromolecules in AD, the pathophysiological mechanisms underlying the production and processing of APP from gene to A are controversial; overexpression, differential splicing or altered metabolism of APP can occur (Checler, 1995; Hyman et al., 1993; . Several lines of evidence suggest that overexpression of APP leads to the increased production of A in DS (Checler, 1995) , and that altered metabolism of APP increases A formation in some cases of familial AD with APP gene mutations . Increased messenger RNA expression of the 695 and 751 amino-acid isoforms of APP in aging, considered to be a major factor in the development of AD, has been described (Sirinathsinghki et al., 1995) , as well as neuronal accumulation of APP (Nakamura et al., 1994) . Increases in the production or neuronal and glial content of APP have been observed after lesioning, but not A accumulation (Palacios et al., 1995; Wallace et al., 1995) . On the other hand, overexpression of the APP gene has never been demonstrated in sporadic AD (Scheuner et al., 1996) .
The factors associated with amyloid deposition, which include lesions, glial responses, reduction in blood flow, perturbed energy metabolism, free radicals, cations, NGF, ras, neurotransmitters or neuromodulators, cytokines, some proteins such as apolipoprotein E4 (Apo-E4), are poorly understood (Cosgaya et al., 1996; Giacobini et al., 1996; Hyman et al., 1993; Lee et al., 1999; Mills and Reiner, 1999; Murakami et al., 1998; Rogers et al., 1999; Trommsdorff et al., 1998; Webster et al., 1998) .
To clarify the relationship between the accumulation of APP and amyloid deposits, the analysis of subsets of AD brains with special features of amyloid deposition is of prime importance (Larner, 1997; Wisniewski et al., 1989; Yamazaki et al., 1992) . The present study has therefore been carried out on five cases of AD brains without cerebellar amyloid deposits (A (Ϫ)) in comparison with typical AD cases and twelve (6 young and 6 age-matched) controls to establish the levels of APP accumulation and their neuronal or glial relationships. This A (Ϫ) situation is not unusual, as a significant number of cerebellar amyloid-negative cases have been reported in other published series (Braak et al., 1989; Cole et al., 1993; Joachim et al., 1989) .
Materials and methods

Cases
Post-mortem cerebella from 5 individuals with a clinical diagnosis of AD and a histopathological 'absence of cerebellar amyloid deposits' (ADA (Ϫ)), 6 age-matched controls, 6 young controls (aged 21, 21, 31, 31, 42 and 52 years) and 6 age-matched AD cases with prominent cerebellar accumulations of amyloid deposits (ADA (ϩ)) were employed in this study. ADA (Ϫ) cases were found in a revision study of a series of 77 AD cases. The criteria for including AD cases were: a) age range 70-76 years; b) clinical AD for 5-6.5 years; c) mobility and motor co-ordination similar to that of normal individuals of the same age before death; d) absence of signs or symptoms indicative of cerebellar pathology up to 60 days before death (criteria c) and d) were evaluated by the patient's primary care physician or hospital neurologist); e) autopsy performed 6-9 h after death; f) brains fixed by immersion in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 3-5 months at 0-4°C; and g) histopathological changes compatible with AD by current criteria (Khachaturian, 1985; Mirra et al., 1993) . In the ADA (Ϫ) group cerebellar amyloid deposits were absent on routine pathological screening, which included Nissl and Bielschowsky methods, and other silver stains and/or immuno A -demonstration. All five cases in this group were female (Table 1) . DNA was extracted from fresh tissue and Apo-E genotyping was performed by PCR-RFLP (Wenham et al., 1991) . Apo-E E4 was observed in only two cases (Table 1) . The controls and age-matched ADA (ϩ) cases were of the same sex and similar Apo-E genotypes. The age-matched ADA (ϩ) group presented a wide variety of A deposits on routine pathological screening (Nissl, Bielschowsky, immuno A ). Age-matched controls were selected from individuals without history of mental disorders, but meeting the criteria a, c, d, e and f. All displayed "absence of cerebellar amyloid deposits". Young controls were persons who had died in accidents.
Tissue processing
In all cases, a 6-7 mm thick sample of the middle part of the simplex lobule was obtained for study. The first sub-lobe below the horizontal fissure, consisting of 10-14 folia (Fig. 1) , was used for quantitative analysis. Tissue blocks were incubated successively at 0-4°C in PBS (6 ϫ 12 h), distilled water (1 ϫ 12 h), PBS (6 ϫ 12 h), distilled water (1 ϫ 12 h), PBS (1 ϫ 24 h), 15% sucrose (6 h) and 30% sucrose (72 h). The blocks were rapidly frozen with dry ice and 20 mm-thick sections were cut with a Leitz freezing microtome in parallel with the sagittal plane of development of the Purkinje dendritic tree. Two hundred serial sections were obtained from each block, but only the first three sections from each consecutive group of ten were used, giving a total of sixty sections per block (Fig. 1) .
Immunocytochemistry
Immunocytochemical studies were performed with the following primary antibodies from Boehringer Mannheim, Germany: 22C11 mouse monoclonal antibody raised against a purified recombinant APP fusion protein (APP 60-100), which recognizes an Nterminal epitope on the pre-A4 molecule; anti Alzheimer precursor protein 643-645/ Jonas mouse monoclonal antibody raised against the carboxyl fragment of APP 643-695 , and immunopositive PCs in relation to the line of section of the PC layer of four selected sections from the same case. Each pair of bars corresponds to a section (s1, s2, s90 and s91); s1 and s90 were incubated with anti-APP 60-100 , s2 and s91 with anti-APP . Arrows indicate the points of origin and termination of each folium represented in a and b. "t" is the top of the sub-lobe. The actual length (mm) of the PC line of section from the top of the sub-lobe (0 mm) to the deepest point of either the HF (point "a"; ϩ mm) and the first secondary fissure below HF (point "k"; Ϫ mm), are represented on the abscissa. Note the similarity between the distribution of groups of positive cells in sections s1 and s2, as well as between distributions in s90 and s91. In this case there were folia with a large number of immunopositive PCs (a-d, j-k), and others with a large number of immunopositive glial cells (d-i). These two types of folia are called "strongly" and "weakly" immunopositive folia, respectively, in the text. (PCs black, glial cells grey). d Comparison of the location and density of APP 60-100 -immunopositive PCs along the line of section of the PC layer in ADA (Ϫ) cases 1, 5 and 3 (C1, C5, C3). Each case is represented by a group of bars displaying the location of immunopositive PCs in the line of section of the PC layer of the 19 sections studied (s1, s10, s20, s30, . . . , s170, s190). Black zones indicate a continuous presence of immunopositive cells (e.g. C1). The length of the PC line of section is indicated as in c. Three distribution patterns of immunopositive PCs are seen: homogeneous distribution (C1), heterogeneous distribution (C5) and basal lobe distribution (C3) (APP 643-645), which reacts with intact full-length APP and the cytoplasmic carboxil fragment of APP 643-695; anti-amyloid, Alzheimer polyclonal antibody (A ) raised in rabbits against synthetic A 1-40, which labels senile plaques in AD patient brains. Dot-blot analysis revealed that anti-APP 22C11 did not cross-react with APP 96-110, APP 657-676 or A 1-40 (10 micrograms). Antibody Jonas only detected APP 657-676, and Alz cross-reacted with A 1-40, but there were no reactions with the other peptides (data no shown). Although we are aware that we were measuring APP-like immunoreactivity, for a sake of clarity, we always mention APP. A similar rule was followed in most of published related works. The first section of each group of ten from each AD and control case was incubated with anti-APP 60-100 and the second section with anti-APP 643-695 . Five sections taken at random from the third section of the groups of 10 sections from each case were incubated with anti-A .
Sections for immunocytochemistry were incubated in PBS with 5% goat serum and 0.2% H 2 O 2 for 30 min and processed by the PAP method (Sternberger, 1979) ; the three primary antibodies were used at a dilution of 1 : 500 for 18 h at 0-4°C; second antibodies were anti-rabbit immunoglobulins and anti-mouse immunoglobulins (Sigma, Chemical CO, St. Louis, USA) used at a dilution of 1 : 16 for 4 h; finally, peroxidaseantiperoxidase immune complexes (Sigma, USA) were used as the third layer, with 3,3Ј-diaminobenzidine (DAB) as the chromogen. Tissue sections for localization of A were treated with 98% formic acid for 2 min before incubation with the primary antibody (Cataldo et al., 1996) . As controls, some of the last sections of each set were treated in the same way, except that the primary antibody was omitted. Moreover, preabsorption of the anti-APP and anti-A antibodies with APP 60-117 (prepared by us) or APP 60-92 (ChemProd, Barcelona, Spain); APP 657-676 (Bachem, Bubendorf, Switzerland); and A (1-40) (extracted from AD plaques or Bachem, Bubendorf, Switzerland), respectively, completely abolished the immunocytochemical staining.
᭣
In 3 sections taken at random from the third section of the groups of each case (and in some first sections), a double APP 60-100 /APP 643-695 immunostaining was performed in two steps. The first incubation was carried out with anti-APP 60-100 and staining was developed with the avidin-biotin (ABC)technique (Hsu et al., 1981) using Vectastain (Vector Laboratories, Burlingame, USA) and 3,3Ј-diaminobenzidine (DAB) as chromogen (brown). The second incubation was in anti-APP 643-695 and the antigen-antibody reaction was demonstrated by the ABC method using the alkaline-phosphatase version of Vectastain (blue).
Morphological analysis and quantification
Sections were studied and photographed at 40ϫ, 80ϫ and 400ϫ. Immunopositive Purkinje cells (PC) were classified by shape and size into four groups: normal (similar to those observed in young controls); hypertrophic (with body or dendrites of unusually large diameters, Ͼ70 mm and Ͼ15 mm, respectively); atrophic (with a smaller body, Ͻ30 mm); and dystrophic (with an abnormal shape of the body and/or dendritic tree; see Fig. 2E -H).
The total number of each kind of immunopositive PC in each section, the length of the line of section of the "PC layer" (or contact surface between the molecular layer and the granule cell layer), and the location of immunopositive cells in relation to this line, were assessed with the help of an Image Analyzer using Image-Pro software (Media Cybernetics, MD, USA). From the numerical data for each case, the percentage of each kind of immunopositive PC in all 20 sections, and the PC and molecular glial cell densities in each section (total number of positive Purkinje bodies, or glial cells in the molecular layer, divided by the total length of the line of section of the PC layer) were calculated. From the data on the location of immunopositive cells in each section, longitudinal diagrams were drawn in which the positive groups of PCs and molecular glial cells were located to show their relationship (Fig. 1) . The sub-lobes close to the horizontal fissure (10-14 folia) were represented on a map, joining in order the longitudinal diagrams of either the APP 60-100 or APP 643-695 immunostained sections from the 1st to the 19th group of Fig. 2 . A ADA (ϩ) case 5. Reactivity with anti-A . Heterogeneous groups of diffuse immunopositive deposits were located mainly in the molecular layer (ml). The positions of Purkinje (P) and granule cell layers (gl) are marked (ϫ80). B ADA (Ϫ) case 1. Negative reaction of cellular elements with anti-A in the molecular (ml), Purkinje (P) and granule cell (gl) layers. Only in blood vessels (arrowheads) and the pia mater could amyloid deposits be observed (ϫ45). C Age-matched normal control, case 2. Negative reaction with anti-APP 60-100 in cellular structures of the molecular (ml) and Purkinje (P) layers. Only slight immunoreactivity was observed in some granule cells of the granule cell layer (gl). The pia matter showed intense immunoreactivity in some places (ϫ45). D ADA (ϩ) case 1. Reactivity with anti-APP 60-100 . Strongly immunopositive PC bodies and main dendrites in a region of high A deposition (which are the white areas in these sections stained with anti-APP 60-100 or anti-APP 643-695 ). Granular deposits in neuronal and glial processes are observed more intense and less homogeneous than those in ADA (Ϫ) cases (ϫ170). E-H Morphological types of APP-immunopositive Purkinje neurons in ADA (Ϫ) cases immunostained with anti-APP 60-100 : normal (n), hypertrophic (h), dystrophic (d) and atrophic (a). There is a great difference between hypertrophic (F) and normal dendrites (G, arrowhead) in the molecular layer. In several cases, the presence of an immunonegative PC can be supposed, because thin, positive axon collaterals surround an immunonegative Purkinje-like cell (G, star). Golgi cells (G) and Lugaro cells (L) are seen in E, F and G. Different numbers of immunopositive granule cells can be observed in the vicinity the Purkinje neurons but not granular deposits. E case 2, ϫ170; F case 2, ϫ280; G and H case 5, ϫ170 ᭤ ten sections. The superposition of images from pairs of sections (one stained with anti-APP 60-100 and the other with anti-APP 643-695 ), using the Image Analyzer, allowed PC bodies reacting with both antisera or with only one to be detected, taking into account that PC bodies are 35-65 mm in diameter and the sections 20 mm in thickness. This analysis was complementary to the results obtained by double immunostaining.
Results
Control cases
No A deposits were observed in the cerebellar tissue of the age-matched or young normal controls. In 20% of sections from the age-matched controls, a few diffuse deposits were found in blood vessels and the pia matter. No immunoreactivity was observed in sections from young controls when incubated with anti-APP 60-100 or anti-APP 643-695 under the conditions chosen. Most sections from age-matched controls incubated with anti-APP 60-100 or anti-APP 643-695 did not present positive cellular elements, but in some folia (22%) a small number of isolated positive PCs (from 1 to 4 elements) were found, as well as small groups of 2-8 astrocytes near the pia mater. The general appearance of these folia was similar to the "weakly" immunopositive folia of the AD cases (see below). A strong reaction was also observed in some fragments of adhering pia mater (Fig. 2C) .
ADA (Ϫ) cases
-Amyloid deposits. In these cases, it was verified that there were no A deposits (Fig. 2B) , either as diffuse plaques or as neuritic plaques. In three patients, very small deposits were found around some blood vessels in the white matter. In some instances, cells and blood vessels of the pia mater were strongly immunoreactive (Fig. 2B) .
Amyloid precursor protein immunoreactivity. Many neurons and glial cells showed a positive reaction for APP 60-100 and APP , but the number and intensity of immunopositive cells in each folium or group of folia were widely different, allowing the folia to be classified as "strongly" or "weakly" APPimmunopositive (Figs. 1 and 3) . This was more clearly seen after reconstruction of the sub-lobes with serial sections incubated with anti-APP 60-100 or -APP 643-695 antibodies (Fig. 1a and b) . Strongly immunopositive folia showed very intense reactions in neurons, mainly in PCs (Fig. 3A) , while weak ones showed little or no immunopositivity in the neuronal elements (Fig. 3B) . Cases 1 and 4 presented strongly APP-immunopositive folia, with high reactivity in nearly all the PCs of all the folia of the lobe studied (see Fig. 1d , C1); in these two cases, positive glial cells, mostly in groups of 6 to 24 elements, were randomly located in the folia and showed no particular relation between Fig. 3 . Double immunostaining for APP 60-100 reactivity (brown) and APP 643-695 reactivity (blue). A Part of folia i-j, j-k, section s3, ADA (Ϫ) case 3. In these two folia, almost all PCs were highly immunopositive (cell bodies and main dendrites and granulations were seen in a variable number of granule cells. The dense background in the molecular layer (ml) and less dense background in the granular layer (gl) of these folia may be due to the reaction of thin dendrites (not observed in B. Some blood vessels (v) were stained. This staining pattern is referred to as "strongly immunostained folia" in the text. Two types of PC can be distinguished, some stained both brown and blue (d), and some stained only brown (s) (ϫ40). B Folium f-g, section s3, ADA (Ϫ) case 3. Glial cells in the upper part of the molecular layer (ml) of a "weakly' immunopositive folium. Most presented double immunostaining but some elements or groups of cells showed only brown (APP 60-100 ) immunostaining (arrows). Neurons were negative (ϫ45). C and D Higher magnification of strongly positive PCs showing single or double immunostaining (ADA (Ϫ) cases 4 and 5, respectively) (ϫ170). gl granule cell layer; ml molecular layer; P Purkinje cell layer; w white matter ᭤ consecutive sections studied (taking into account that only 1 in each group of 10 sections was studied). Cases 2 and 3 had special characteristics: strongly positive folia appeared in the bottom of the sub-lobe (symmetrically located on both sides of the midplane passing through the white matter), while weakly APP-immunopositive folia, with a constant presence of positive glial cells (Ͼ30 cells/mm), appeared near the top of the sub-lobe (Figs. 1a-c) and 1d, C3). Case 5 showed an irregular distribution of positive and negative elements in the folia, as could be observed in consecutive sections (Fig. 1d, C5 ). The most heavily stained cells were Purkinje neurons ( Fig. 2 and 3) , some glial cells in the external part of the molecular layer (Fig. 3) , and a small number of Golgi, Lugaro and granule cells (Fig. 2) . located mainly in the upper part of the granular layer.
In heavily stained PCs, the largest dendrites presented a prominent reaction which could be observed as far as the external third of the molecular layer (Figs. 2 and 3 ). Hypertrophic dendrites with a high level of immunoreactivity could be seen in many random locations (Fig. 2) . The percentages of hypertrophic, dystrophic or atrophic positive PCs were different in each case, but the largest percentage corresponded to those of "normal" size and shape (Table 1) . Dystrophic PCs of intense immunoreactivity were observed (Ͻ12.6%; Fig. 2 ), but atrophic PCs displayed variable immunoreactivity, with a special tendency to show non-homogeneously stained cell bodies (Fig. 2) . Immunonegative PC bodies were probably present in several folia of generally strong immunopositivity, as no immunopositive PC bodies were observed in long stretches of the Purkinje "layer" and thin immunopositive Purkinje axon collaterals were seen surrounding Purkinje-like immunonegative cells (Fig. 2) . In the strongly immunopositive folia, there was a dense, homogeneous background in addition to the many large and clearly delimited immunopositive dendrites. This contrasted with the clearer appearance of the molecular layer in controls and in the weakly immunopositive folia.
Analysis of the serial sections that presented the same Purkinje neurons in both sections showed that most PCs (76%) reacted with both anti-APP 60-100 and anti-APP 643-695 , while 24% reacted with only one of these antibodies (anti-APP 60-100 in 82% of these cases). This was confirmed by analysis of the doublestained sections (Table 2) .
Other neuronal types with positive, but variable, reactions were Lugaro and Golgi cells (Fig. 2E-G) . The heavily stained cells of these types represented less than 10% of the neurons detected in sections stained with the Bielschowsky method. No positive cells were found that could be identified as stellate or basket cells. Granule cells were of quite variable reaction. Only a very small number of these cells could be clearly observed with the typical appearance of small stellate cells. However, in many folia with a strong reaction, many granular deposits were observed in granule cells (Fig. 3A) . The immunopositive background of the granule cell layer was less dense than that of the molecular layer.
APP-immunopositive glial cells were seen in all cases. The most characteristic positive elements were small cells with the size and appearance of astrocytes or microglial cells. As mentioned above, these cells were generally grouped in the external part of the molecular layer; in strongly immunopositive folia, isolated cells or groups of 6-24 elements were observed in the sections, and in weakly immunopositive folia, groups of more than 50 cells were noticed (Fig. 3B) . A continuous "sublayer" of a high density (Ͻ30 cell/mm "Purkinje cell line") of strongly immunopositive glial cells, extending over several weakly immunopositive folia, was seen in cases 2 and 3 of the ADA (Ϫ) group ( Fig. 1a-c; Fig. 3 ). In general, the greater the density of immunopositive glial cells, the less was the density of immunopositive PCs (Table 1) . Immunopositive endothelial and perithelial cells could be observed in several blood vessels, mainly in the white matter (Fig. 3A) and, in some instances, in small zones of the adhering pia mater.
Differences between anti-APP 60-100 and anti-APP immunostaining. Sections treated with anti-APP 643-695 displayed reactivities similar to those incubated with anti-APP 60-100 , but some differences were observed: a) fewer APP 643-695 -positive PCs were seen (2.7-20.8%); b) APP 643-695 staining showed more granular deposits in PCs and glial cells; c) APP 643-695 immunopositivity was more variable in the cell types stained; d) more isolated APP 643-695 -positive PCs were seen in weakly immunopositive folia; e) fewer APP 643-695 -positive Lugaro or Golgi cells were found; f) only APP 643-695 staining revealed granular deposits in glial cells in the PC layer (Golgi epithelial cells or astrocytes).
AD A(ϩ) cases
In these cases the accumulation of -amyloid was confirmed. In all sections studied, most folia contained diffuse deposits of different shapes and sizes, located preferentially in the molecular layer extending from the PC layer to the pia mater ( Fig. 2A) , or in the upper part near the pia mater. Very few randomly distributed neuritic plaques were observed.
Incubation of sections with anti-APP 60-100 and anti-APP 643-695 produced a picture similar to the strongly immunostained folia described above. The number of weakly immunostained folia was small (0-17%) in all these cases. The types of positive cells observed were the same as those described in ADA (Ϫ) cases; PCs and glial cells in the upper part of the molecular layer were the most reactive. The percentages of positive dystrophic and atrophic PCs were higher than those in the ADA (Ϫ) cases (Table 1) . In general, the immunopositive background was more intense and less homogeneous. Very small granular deposits appeared in all layers, corresponding to prolongations of neurons or glial cells. In the regions of the molecular layer showing a high density of granular A deposition, a "negative" picture of medium-size white patches was observed after APP 60-100 or APP 643-695 immunostaining (Fig. 2D) . In the few neuritic plaques observed, APP-immunopositive dystrophic neurites surrounded a white core. Only one case displayed higher densities of APP-immunopositive neurons in the folia near the bottom of the sub-lobe (similar to cases 2 and 3 of the ADA (Ϫ) group), but in this case the folia at the top of the sub-lobe were markedly immunopositive. The A deposits showed the same pattern in this case.
Discussion
In certain cases of Alzheimer's disease, no amyloid deposits have been found in the cerebellum despite the use of sensitive techniques (Braak et al., 1989; Joachim et al., 1989; Cole et al., 1993) . However, the presence of APP in the cerebellar cells has never been investigated in these cases. In the present work, five cases of this type of AD have been analysed. Each shows an accumulation of APP in neurons (mainly PCs) and glial cells (especially those located in the upper part of the molecular layer) far greater than that which appears in brains of elderly people not suffering from AD, and similar to that observed in AD cerebella with a high degree of A deposition. In "normal" control brains processed and studied under the present conditions, the APP content of most neuronal and glial elements appeared to be below the limit of immunochemical detection. The results suggest that an accumulation of amyloid precursor proteins could be a more characteristic feature of AD cerebella than amyloid deposition.
These AD A(Ϫ) cases could be considered as: 1) an early stage in the AD cerebellar accumulation of amyloid, in which the overexpression and/or altered metabolism of APP is a prior step to amyloid deposition; or 2) a special AD subtype in which unknown factors prevent or remove amyloid deposits in some CNS regions.
ADA (Ϫ) cerebella may be assumed to be in an early phase of the neurodegenerative disease (patients died 6.0 Ϯ 0.5 years after diagnosis, as compared with an average survival of approximately 11 years for AD patients in Spain); however, age-matched AD A(ϩ) individuals with the same criteria for inclusion in this study (age, sex, time after diagnosis) displayed a high content of A deposits. Moreover, amyloid deposits seem to take many years to form (Beyreuther and Masters, 1991) .
APP overexpression similar to that in patients with DS who develop AD has not been clearly demonstrated in sporadic AD (Scheuner et al., 1996) . Other metabolic mechanisms that might explain APP accumulation, such as the presence of increased levels of APP messenger RNAs (Sirinathsinghki et al., 1995) or increased production of amino-terminal fragments of APP (Nakamura et al., 1994) , are age-related and therefore also apply to the agematched controls. Two major group of hypotheses have been proposed concerning the mechanism of amyloid deposition (Multhaup et al., 1996) . In one group, the key idea is that synaptic and axonal injury may lead to the formation of dystrophic neurites with accumulation of APP and may precede the deposition of A (Giaccone et al., 1989; Cork et al., 1990; Su et al., 1998; Thal et al., 1998) . The alternative point of view is that diffuse A constitutes the first abnormality (Rumble et al., 1989; Verbeek et al., 1997) . Ours results clearly give the primacy to APP accumulation, even before the dystrophic alterations of neurites and the preamyloid deposition, as suggested by Su et al. (1998) . In agreement with important authors (Bunnell et al., 1998; Kouchi et al., 1998; Mills and Reiner, 1999; Multhaup et al., 1996; Sheetz et al., 1998; Simons et al., 1995) , our observed accumulation of APP in AD, and its theoretical disease induction capacity, could be mediated by disruption of the normal intraneuronal trafficking/metabolism of APP. In this situation, we have to consider the existence of factors that would trigger, prevent or remove APP/A accumulation by changes in APP metabolism, as has been suggested by other authors (Armstrong et al., 1995; Cosgaya et al., 1996; Hyman et al., 1993) .
It would be of great interest to know the factors leading to the special preservation of amyloid deposits in those cases or brain regions in which they are seen, both for understanding the pathophysiology of AD and for developing new lines of treatment. In our study, age, Apo-E genotype and time after diagnosis have not been factors in differentiating ADA (Ϫ) and ADA (ϩ) cases. Sex may, however, be a factor, as all the A -negative cases were female, but the limited number of cases does not permit us to conclude that sex is a common factor.
We wish to draw attention to the following results, which could be useful in the study of possible factors that prevent A accumulation or are involved in A deposition:
1) The main accumulation of APP occurred in two different cell types, Purkinje neurons and glial cells, corresponding to the different origins of amyloid already described (Banati et al., 1993; Dickson, 1997; Palacios et al., 1995) . In cases 2, 3 and 5 of the ADA (Ϫ) group, in which many folia presented immunoreactive or non-immunoreactive PCs (in "strongly" or "weakly" immunopositive folia), the possible sources of future amyloid deposits were distributed separately: there were zones or folia with a high accumulation of immunopositive neurons, and others with an accumulation of immunopositive glial cells. Moreover, the two cases with the highest neuronal immunoreactivity (1 and 4) presented the lowest content of immunopositive glial cells in the molecular layer. This was similar in the ADA (ϩ) cases. Our results suggest that there could exist an initial dual origin (neural or glial) of amyloid which may produce different neuropathologies. APP-immunopositive glial cells may promote diffuse amyloid deposits in the molecular layer, which is a normal feature in the cerebella of AD brains (Joachim et al., 1989; Kida et al., 1995; Tamaoka et al., 1995; Yamaguchi et al., 1989) with little damage to neurons.
2) Only a small group of immunopositive Purkinje neurons (Ͻ35%, taking hypertrophic, dystrophic and atrophic cells together) was accompanied by morphological alterations in the ADA (Ϫ) cases, but the percentage was far greater in ADA (ϩ) cerebella. APP accumulation thus seems to precede morphological involutive changes.
3) PCs were the most immunoreactive neurons; Golgi, Lugaro and granule cells were positive, but with highly variable reactivity, and stellate and basket cells were always negative. This confirms the cell specificity of pathological changes in AD (Braak et al., 1996; Johnson et al., 1989) . But the existence of three sets of immunopositive Purkinje neurons (APP 60-100 , APP 643-695 and APP 60-100 /APP ) suggests that the metabolism of the isoforms of APP is highly complex (Le Blanc et al., 1996; Marquez-Sterling et al., 1997; Selkoe et al., 1996) and may depend on neuronal and extraneuronal factors acting locally, as has previously been suggested (Armstrong et al., 1995; Cataldo et al., 1996; Cosgaya et al., 1996; Hyman et al., 1993; Sirinathsinghki et al., 1995) . A disease mechanism leading to these different sets of immunopositive neurons could be the proposed misregulation of trafficking and closely related mismetabolism of APP (Bunnell et al., 1998; Kouchi et al., 1998; Mills and Reiner, 1999; Multhaup et al., 1996; Sheetz et al., 1998; Simons et al., 1995) . Similarly, the appearances suggest the existence of extracellular factors that operate in small or large zones (from one part of a folium up to several folia, either on one side or on both sides of the central white matter of a sub-lobe) to induce the accumulation of APP, either in neurons or glial cells. These factors may not be specific to a particular type of cell, as they induce APP accumulation in neurons, glial cells, and blood-vessel cells, but some cell types (stellate or basket cells) or cell types in special situations (Golgi, Lugaro and granule cells) seem to be spared. Areas of more marked pathological change were first pointed out by Braak et al. (1989) , who described a higher amyloid deposition in the folia near the bottom of the sublobes. All the intracellular or extracellular, general or local, neuronal or glial putative factors inducing APP mismetabolism/A deposition (Cosgaya et al., 1996; Giacobini et al., 1996; Hyman et al., 1993; Lee et al., 1999; Mills and Reiner, 1999; Murakami et al., 1998; Rogers et al., 1999; Trommsdorff et al., 1998; Webster et al., 1998) need to be investigated in this subset of AD brains with special features of APP and A deposits.
Further investigation will be necessary for the morphological and histochemical classification of the glial cells observed in this study, since a wide variety of glial cells are capable of synthesizing APP, including normal, hypertrophic and reactive glia, astroglia, oligodendroglia and microglia (Banati et al., 1993; Eddleston et al., 1993; Palacios et al., 1995; Wisniewski et al., 1991) . Cell-specific expression of APP isoforms in glial cells has also been described (Rohan da Silva et al., 1997) . In addition, the relationship of APP and A immunoreactivities in the ADA (ϩ) cases needs further analysis.
The homogeneous APP background staining of the molecular layer in the ADA (Ϫ) cases and the heterogeneous background staining of regions in the ADA (ϩ) cases with a high A content suggest that a positive background corresponds to small neuronal and glial prolongations and not to A -positive structures. However, some APP immunopositivity has been described in amyloid deposits (Cole et al., 1993) .
In summary, the high APP accumulation in neurons (mainly Purkinje cells and some specific glial cells) in the cerebella of AD cases is not completely related to Apo-E 4 genotype of amyliod deposit because our cases were devoid of amyloid burden and possesed different Apo-E genotypes (see Table  1 ). Moreover, the different patterns of APP-positive folia support the idea that APP production/metabolism and A deposit are complex processes probably regulated by a number of general, but local, factors.
